Faced with the most aggressive cancers, studies may have a new weapon: an innovative nanotechnology -based vaccine that manages to block the disease in 88% of cases tested ....
The failed cancer, search may have new weapons: New and creative cattle at the University of Massachusetts.
In decades, medicine facing its efforts, disloyal treatment and mmnidapy.bun the rabbery to serve, which may have taken action.Mobile phones, between a half between Nanotechnology and appearance, is permitted to indicate cancer CCL COLCER.
Innovative technology based on Nanot's particles
Vaccination, developed in amhpetts university but conflict: using the nanopatches to get on immunity and the prisoners.Nanotarlili worked as vehicles for two buttons:
Antique antiques are taken from a swollen cell that allows the immune system to recognize cancer;
Adjuvant, molecules who strongly stimulate immune defenses so that they can respond effectively.
"Engineering, the nanoparticles increase the system immune system, we can prevent cancer with living organisms.
Only antibiotics pictures, this medicine is only on multiple faces.
"Vaccines of the hand creates natural immune system and resisted, which allows immune resolves per field," explains the investigation.
Extraordinary results in mice
Scientists have tested vaccines on different types of cancer to treat Melonyma, a cancer that promotes risk, so their pictures know the cells.
The results are amazing:
About 88% of mice exposed to pancreatic cancer cells were free.
75% of rats are damaged on the chest of negative breasts that did not improve the gaps;
69% of rats were cursed with melanesma cells shed by tumors.
But not all of this: cancers cancer and prevented vaccine to other organs like the lungs.
Vaccinated mice developed real systemic immune memory and their bodies managed to defend themselves against the tumor reflection several months later.
This study is a large sign in the war with the most powerful cancer.And the product will be established to prevent cancer and powerful treatment.
To accomplish this ambition, researchers have created a launch, Nanovax Therapeutics, trying to turn the technology into clinical protocols.